ASVGX
Price
$10.48
Change
-$0.45 (-4.12%)
Updated
Dec 18 closing price
VSIAX
Price
$85.23
Change
-$3.35 (-3.78%)
Updated
Dec 18 closing price
Ad is loading...

ASVGX vs VSIAX

Header iconASVGX vs VSIAX Comparison
Open Charts ASVGX vs VSIAXBanner chart's image
American Century Small Cap Value R5
Price$10.48
Change-$0.45 (-4.12%)
VolumeN/A
CapitalizationN/A
Vanguard Small Cap Value Index Admiral
Price$85.23
Change-$3.35 (-3.78%)
VolumeN/A
CapitalizationN/A
ASVGX vs VSIAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
ASVGX vs. VSIAX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASVGX is a Hold and VSIAX is a Hold.

FUNDAMENTALS
Fundamentals
VSIAX has more cash in the bank: 63B vs. ASVGX (5.19B). VSIAX pays higher dividends than ASVGX: VSIAX (2.01) vs ASVGX (1.08). ASVGX was incepted earlier than VSIAX: ASVGX (8 years) vs VSIAX (13 years). ASVGX is a more actively managed with annual turnover of: 44.00 vs. VSIAX (16.00). ASVGX has a lower initial minimum investment than VSIAX: ASVGX (0) vs VSIAX (3000). VSIAX annual gain was more profitable for investors over the last year : 16.23 vs. ASVGX (7.18). VSIAX return over 5 years is better than : 52.83 vs. ASVGX (39.36).
ASVGXVSIAXASVGX / VSIAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence8 years13 years-
Gain YTD5.27115.03135%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets5.19B63B8%
Annual Yield % from dividends1.082.0154%
Returns for 1 year7.1816.2344%
Returns for 3 years-0.8120.67-4%
Returns for 5 years39.3652.8375%
Returns for 10 yearsN/A105.65-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ALTO1.470.04
+2.80%
Alto Ingredients
ADXN7.80-0.05
-0.64%
Addex Therapeutics Ltd
DCOM33.96-0.84
-2.41%
Dime Community Bancshares
CAVA123.37-3.42
-2.70%
CAVA Group
EWTX30.17-2.52
-7.71%
Edgewise Therapeutics